The Pfizer drugs Cost Plus Drugs said it will sell are Duavee, Estring, Premarin, Premphase and Prempro, which are all menopause drugs, according to a May 24 tweet from the company. A release date was not provided.
Cost Plus Drugs launched as a company focused on selling low-cost drugs with a 15 percent markup, a $3 pharmacy labor fee and a $5 shipping cost. Seventeen months after launching with a few dozen products, Cost Plus Drugs now offers more than 1,000 pharmaceuticals.
A high percentage of those are generics, though, and brand-name drugs account for 80 percent of drug spending in the U.S. despite making up only 10 percent of prescriptions filled, according to a 2020 report from the Association for Accessible Medicines. Cost Plus Drugs broke into the brand-name drug market in March before grabbing three Johnson & Johnson drugs the next month.
